• Most Popular
  • Most Shared

Array, Celgene form drug partnership

Mon Sep 24, 2007 11:33am EDT

Stocks

   

(Updates with details)

NEW YORK, Sept 24 (Reuters) - Celgene Corp (CELG.O) said on Monday it will pay $40 million for the option to license certain drugs being developed by Array BioPharma Inc (ARRY.O)

Under the agreement, which is focused on the development of drugs for cancer and autoimmune disorders, Celgene will have the opportunity to select two out of four mutually selected drug candidates.

Array will be responsible for early discovery and early clinical development. Celgene will then have the option to select one or two drugs and will receive world-wide licenses to them, except for limited co-promotional rights for Array in the United States.

Array will receive potential clinical and commercial milestone payments per drug of about $500 million, as well as royalties on net sales.

(Reporting by Lewis Krauskopf and Toni Clarke)

((Editing by Dave Zimmerman; Reuters Messaging: Lewis.Krauskopf.reuters.com@reuters.net; lewis.krauskopf@reuters.com; 646-223-6000)) Keywords: ARRAY CELGENE/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nN24273390


More from Reuters

Joint Terminal Attack Controller SSgt Clinton J. Herbison, a U.S. Airman from the 817 Expeditionary Air Support Operations Squadron (EASOS) takes a break during a night mission near Honaker Miracle camp at the Pesh valley of Kunar Province August 12, 2009. Credit: REUTERS/Carlos Barria

Pictures of the Year

A look at the best photos of 2009.  Slideshow 

    PICTURES
    The Dalai Lama jokes with a nasal spray after being asked his opinion on the swine flu during a press conference after his first lecture in Lausanne, Switzerland, August 4, 2009. REUTERS/ Valentin Flauraud

    What a wacky year it's been...

    Um, what's up the Dalai Lama's nose? "Oddly Enough" editor Bob Basler rounds up the goofiest photos of the year.  Full Article 

    Oddly Enough
    A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
    Political Risk in 2010:

    Don't say we didn't warn you

    With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

    Global Markets